Abbott India Ltd (ABBOTINDIA) - Financial and Strategic SWOT Analysis Review

August 2021 | 44 pages | ID: AE0DD20A304EN
GlobalData

Abstracts

Abbott India Ltd (ABBOTINDIA)

Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Abbott India Ltd (Abbott India), a subsidiary of Abbott Laboratories, discovers, develops, manufactures and markets a diverse range of branded generic pharmaceuticals, diagnostic tools, nutritional products, and diabetes and vascular devices. Its product portfolio encompasses multi-specialty drugs, vitamins and a comprehensive range of products for the treatment of hypothyroidism, vertigo, epilepsy, depression and migraine. The company’s offerings also include vaccines for influenza, typhoid and diarrhea. Abbott India develops pharmaceuticals in various formulations including tablets, liquids, injectables, ointments, granules, powder and capsules. The product range helps treat gynecological, gastroenterological, urological and neurological diseases, diabetes, pain and infection. Abbott India is headquartered in Mumbai, Maharashtra, India and has a manufacturing facility in Goa, India.

Abbott India Ltd Key Recent Developments

Sep 25,2020: Abbott Laboratories announces board changes
Jun 22,2020: Abbott: Intimation of resignation of Director
Jun 08,2020: Abbott India: Appointment of Managing Director
Feb 18,2020: Abbott India: Change in Directors

Requlation 30 of Securities and Exchange Board of India

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Abbott India Ltd - Key Facts
Abbott India Ltd - Key Employees
Abbott India Ltd - Key Employee Biographies
Abbott India Ltd - Major Products and Services
Abbott India Ltd - History
Abbott India Ltd - Company Statement
Abbott India Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Abbott India Ltd - Business Description
Abbott India Ltd - Corporate Strategy
Abbott India Ltd - SWOT Analysis
SWOT Analysis - Overview
Abbott India Ltd - Strengths
Abbott India Ltd - Weaknesses
Abbott India Ltd - Opportunities
Abbott India Ltd - Threats
Abbott India Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Abbott India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Abbott India Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Abbott India Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Sep 25, 2020: Abbott Laboratories announces board changes
Jun 22, 2020: Abbott: Intimation of resignation of Director
Jun 08, 2020: Abbott India: Appointment of Managing Director
Feb 18, 2020: Abbott India: Change in Directors - Requlation 30 of Securities and Exchange Board of India

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Abbott India Ltd, Key Facts
Abbott India Ltd, Key Employees
Abbott India Ltd, Key Employee Biographies
Abbott India Ltd, Major Products and Services
Abbott India Ltd, History
Abbott India Ltd, Other Locations
Abbott India Ltd, Key Competitors
Abbott India Ltd, Ratios based on current share price
Abbott India Ltd, Annual Ratios
Abbott India Ltd, Annual Ratios (Cont...1)
Abbott India Ltd, Annual Ratios (Cont...2)
Abbott India Ltd, Interim Ratios
Abbott India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Abbott India Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Abbott India Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Abbott India Ltd, Performance Chart (2017 - 2021)
Abbott India Ltd, Ratio Charts
Abbott India Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Abbott India Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021